Additionally, the target genes were also enriched in the binding motif of Wilms' tumor 1 (WT1), a developmental transcription factor commonly dysregulated in hematologic malignancies and solid tumors such as breast cancer, ovarian cancer and glioblastoma [47]. This evidence concerns the gene WT1 and breast cancer.